ArticleAntioxidants (Basel, Switzerland)2020

Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus.

Eui Joo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.